Identification of the Top 10 Core Genes as Diagnostic and Therapeutic Targets in Hepatocellular Carcinoma (HCC)
Identification of the Top 10 Core Genes as Diagnostic and Therapeutic Targets in Hepatocellular Carcinoma (HCC)
Qiangsheng Wu1, Yumei Yin2, Hui Gao1, Baoding Chen3, Jianjun Yu2, Jian Zhang4, Donglai Zhu5, Fang Liu6, Guohong Ge7 and Ya-Mei Dang8*
ABSTRACT
Lacking specific diagnostic markers for hepatocellular carcinoma is the critical reason for its increasing mortality. In this study, a microarray containing 24 hepatocellular carcinoma patients’ tumor tissues were compared to 8 normal liver tissues to screen out the significant abnormal expressed genes. The potential interactions and mechanisms of these genes in promoting hepatocellular carcinoma were analyzed through bioinformatics analysis. The results showed that the functions of these 1495 differently expressed genes enriched in cell cycle, oxidation-reduction and drug metabolic process. Additionally, the top 10 core genes of these differently expressed genes were mainly participated in cell cycle and strongly correlated with worse prognosis of survival, which may be potential diagnostic and therapeutic targets of HCC.
To share on other social networks, click on any share button. What are these?
